07/11/2025
3:46 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/09/2025
3:30 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2025
7:15 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/23/2025
12:50 PM | Sanders Corazon D. (0001796536) (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
5:31 PM | Ray Amrit (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
5:31 PM | Dunsire Deborah (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
5:32 PM | Fust Matthew K (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
5:32 PM | NARACHI MICHAEL (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
5:33 PM | Sanders Corazon D. (0001796536) (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
5:33 PM | Ultragenyx Pharmaceutical (Issuer)
WELCH DANIEL G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
5:34 PM | SULIMAN SHEHNAAZ (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for RARE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Ultragenyx Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. |
05/05/2025
6:18 PM | Crombez Eric (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/24/2025
8:12 AM | BlackRock, Inc. (Filed by)
Ultragenyx Pharmaceutical (Subject)
| Form SCHEDULE 13G/A | |
03/28/2025
4:00 PM | Ultragenyx Pharmaceutical (Filer)
| Form DEF 14A | |
03/28/2025
4:01 PM | Ultragenyx Pharmaceutical (Filer)
| Form DEFA14A | |
03/28/2025
4:02 PM | Ultragenyx Pharmaceutical (Filer)
| Form ARS | |
03/10/2025
11:53 AM | Horn Howard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
7:16 PM | Crombez Eric (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
7:18 PM | Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
7:19 PM | Kassberg Thomas Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:56 PM | Horn Howard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
7:00 PM | Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
7:02 PM | Huang Dennis Karl (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
7:06 PM | Harris Erik (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
7:10 PM | KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
7:12 PM | Pinion John Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
12:58 PM | Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
3:58 PM | Ultragenyx Pharmaceutical (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/12/2025
10:42 AM | SANDS CAPITAL MANAGEMENT, LLC (Filed by)
Ultragenyx Pharmaceutical (Subject)
| Form SCHEDULE 13G/A | |
02/10/2025
9:25 AM | Ultragenyx Pharmaceutical (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
01/13/2025
7:30 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/31/2024
1:05 PM | KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
3:32 PM | KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/19/2024
3:17 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2024
7:30 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2024
5:44 PM | KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
5:47 PM | Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
3:12 PM | KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
5:42 AM | RTW INVESTMENTS, LP (Filed by)
Ultragenyx Pharmaceutical (Subject)
| Form SC 13G/A | |
11/05/2024
3:06 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2024
3:48 PM | Horn Howard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
New crypto laws coming. Will you win or lose? (Ad) Washington’s first-ever “Crypto Week” could trigger a major Bitcoin surge — but one trader says don’t just buy and hold.
Larry Benedict’s “Bitcoin Skimming” strategy is built to extract 6x, 9x, or even 22x more profit from the same Bitcoin moves. He’s revealing exactly how it works in a free video. Watch the Bitcoin Skimming strategy here |
10/07/2024
7:15 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
3:34 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2024
12:03 PM | Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
10:50 AM | Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
10:53 AM | KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
3:40 PM | KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
1:48 PM | KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
3:28 PM | KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
